Bosh sahifaABUS • NASDAQ
add
Arbutus Biopharma Corp
4,06 $
Seans yopilganidan keyin:(0,49%)-0,020
4,04 $
Yopilgan:16-yan, 20:00:00 (GMT-5) · USD · NASDAQ · Ogohlantirish
Yopilish kursi
4,70 $
Kunlik diapazon
3,68 $ - 4,20 $
Yillik diapazon
2,71 $ - 5,10 $
Bozor kapitalizatsiyasi
780,84 mln USD
Oʻrtacha hajm
1,27 mln
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 529,00 ming | -60,49% |
Joriy xarajat | 3,04 mln | -32,91% |
Sof foyda | -7,74 mln | 60,73% |
Sof foyda marjasi | -1,46 ming | 0,61% |
Har bir ulushga tushum | -0,06 | 59,57% |
EBITDA | -8,28 mln | 51,67% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 93,70 mln | -26,68% |
Jami aktivlari | 97,71 mln | -30,43% |
Jami passivlari | 20,31 mln | -39,46% |
Umumiy kapital | 77,40 mln | — |
Tarqatilgan aksiyalar | 192,32 mln | — |
Narxi/balansdagi bahosi | 11,75 | — |
Aktivlardan daromad | -20,63% | — |
Kapitaldan daromad | -24,39% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -7,74 mln | 60,73% |
Operatsiyalardan naqd pul | -5,82 mln | 71,95% |
Sarmoyadan naqd pul | -10,02 mln | 16,41% |
Moliyadan naqd pul | 844,00 ming | -52,45% |
Naqd pulning sof oʻzgarishi | -15,00 mln | 51,51% |
Boʻsh pul | -2,55 mln | 76,57% |
Haqida
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia
Tashkil etilgan
2007
Sayt
Xodimlar soni
44
